skip to Main Content
MRIGlobal To Test System For Akonni Biosystems Device

MRIGlobal to test system for Akonni Biosystems Device

  • February 8, 2019

Akonni Biosystems, a molecular diagnostics (MDx) company that develops, manufactures, and intends to market advanced MDx systems, today announced receipt of a $3 million, three-year Phase II Small Business Innovation Research (SBIR) contract from the National Institute of Allergy and Infectious…

Read More